CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmaceutical company in the world.

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | Presiding over the upward trajectory of Eli Lilly over the last eight years is ...

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...

David Ricks, Eli Lilly’s chief executive officer, told CNN that the company – whose revenue grew 32% to $45 billion last year on the back of its diabetes and weight loss drugs – wanted to ...

Johnson & Johnson (JNJ) is joining Eli Lilly (LLY) in attempting to court favor with President Donald Trump by announcing ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. "It's about the size of a small city," says David Ricks, Eli Lilly's CEO. That's about 10% of the 1 ...

so we need to see those either extended or improved to support this,” Eli Lilly CEO David Ricks said at a press conference in Washington, DC. The move was touted by Commerce Secretary Howard ...

Advertisement Eli Lilly chairman and Chief Executive Officer David Ricks in a news release on Wednesday said the new U.S. manufacturing sites will support the firm's efforts to produce medicines ...

Eli Lilly (LLY) CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmaceutical company in the world.